NO973715L - Transdermal formulering - Google Patents

Transdermal formulering

Info

Publication number
NO973715L
NO973715L NO973715A NO973715A NO973715L NO 973715 L NO973715 L NO 973715L NO 973715 A NO973715 A NO 973715A NO 973715 A NO973715 A NO 973715A NO 973715 L NO973715 L NO 973715L
Authority
NO
Norway
Prior art keywords
azabicyclo
octane
butylthio
thiadiazol
transdermal
Prior art date
Application number
NO973715A
Other languages
English (en)
Norwegian (no)
Other versions
NO973715D0 (no
Inventor
Franklin Porter Bymaster
Harlan E Shannon
Lisa Ann Shipley
Kirti H Valia
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO973715L publication Critical patent/NO973715L/no
Publication of NO973715D0 publication Critical patent/NO973715D0/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061Polyacrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/02Adhesive bandages or dressings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO973715A 1995-02-17 1997-08-12 Transdermal formulering NO973715D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39044595A 1995-02-17 1995-02-17
US48101695A 1995-06-07 1995-06-07
PCT/US1996/001371 WO1996025154A1 (en) 1995-02-17 1996-02-01 Transdermal formulation

Publications (2)

Publication Number Publication Date
NO973715L true NO973715L (no) 1997-08-12
NO973715D0 NO973715D0 (no) 1997-08-12

Family

ID=27013141

Family Applications (1)

Application Number Title Priority Date Filing Date
NO973715A NO973715D0 (no) 1995-02-17 1997-08-12 Transdermal formulering

Country Status (22)

Country Link
US (1) US5858393A (cs)
EP (1) EP0727208B1 (cs)
JP (1) JPH11505513A (cs)
KR (1) KR19980702239A (cs)
CN (1) CN1181007A (cs)
AR (1) AR002027A1 (cs)
AU (1) AU700023B2 (cs)
BR (1) BR9607722A (cs)
CA (1) CA2212874A1 (cs)
CO (1) CO4700408A1 (cs)
CZ (1) CZ255097A3 (cs)
DE (1) DE69614419T2 (cs)
ES (1) ES2159683T3 (cs)
FI (1) FI973362A (cs)
HU (1) HUP9802070A3 (cs)
IL (1) IL116997A0 (cs)
NO (1) NO973715D0 (cs)
NZ (1) NZ302147A (cs)
PE (1) PE17897A1 (cs)
TR (1) TR199700799T1 (cs)
WO (1) WO1996025154A1 (cs)
YU (1) YU6196A (cs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6528529B1 (en) 1998-03-31 2003-03-04 Acadia Pharmaceuticals Inc. Compounds with activity on muscarinic receptors
US6417227B1 (en) 1999-04-28 2002-07-09 Cg And Associates Methods of delivery of cetyl myristoleate
WO2001030316A2 (en) * 1999-10-28 2001-05-03 3M Innovative Properties Company Transdermal drug delivery devices comprising (r)-(z)-1-azabicyclo(2.2.1)heptan-3-one, 0-(3(3-methoxyphenyl)-2-propynyl)oxime
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
US7678363B2 (en) 2005-08-26 2010-03-16 Braincells Inc Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs
US20070264130A1 (en) * 2006-01-27 2007-11-15 Phluid, Inc. Infusion Pumps and Methods for Use
US8986253B2 (en) * 2008-01-25 2015-03-24 Tandem Diabetes Care, Inc. Two chamber pumps and related methods
WO2009143188A2 (en) * 2008-05-19 2009-11-26 Diperna Paul M Disposable pump reservoir and related methods
US7943187B2 (en) * 2008-05-23 2011-05-17 Bakr Rabie Paeoniflorin preparations and uses thereof for fat reduction
US20110097393A1 (en) * 2008-06-25 2011-04-28 US WorldMeade, LLC Skin Patches and Sustained-Release Formulations Comprising Lofexidine for Transdermal and Oral Delivery
US8408421B2 (en) * 2008-09-16 2013-04-02 Tandem Diabetes Care, Inc. Flow regulating stopcocks and related methods
EP2334234A4 (en) * 2008-09-19 2013-03-20 Tandem Diabetes Care Inc DEVICE FOR MEASURING THE CONCENTRATION OF A SOLVED SUBSTANCE AND CORRESPONDING METHOD
EP2932994B1 (en) 2009-07-30 2017-11-08 Tandem Diabetes Care, Inc. New o-ring seal, and delivery mechanism and portable infusion pump system related thereto
US9180242B2 (en) 2012-05-17 2015-11-10 Tandem Diabetes Care, Inc. Methods and devices for multiple fluid transfer
US9173998B2 (en) 2013-03-14 2015-11-03 Tandem Diabetes Care, Inc. System and method for detecting occlusions in an infusion pump

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4316893A (en) * 1975-06-19 1982-02-23 Nelson Research & Development Co. Vehicle composition containing 1-substituted azacycloalkan-2-ones
IT1233860B (it) * 1988-02-08 1992-04-21 Isf Spa Derivati del peridroazacicloalca (1,2-a) imidazolo ad attivita' nootropa
DK198590D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
US5238933A (en) * 1991-10-28 1993-08-24 Sri International Skin permeation enhancer compositions
DE69427537T2 (de) * 1993-08-19 2002-04-04 Novo Nordisk A/S, Bagsvaerd Antipsychotisches verfahren mit thiadiazol- und oxadiazol-derivaten

Also Published As

Publication number Publication date
DE69614419T2 (de) 2002-05-23
HUP9802070A2 (hu) 1999-02-01
AU4774296A (en) 1996-09-04
DE69614419D1 (de) 2001-09-20
CZ255097A3 (en) 1997-12-17
AR002027A1 (es) 1998-01-07
TR199700799T1 (xx) 1998-02-21
AU700023B2 (en) 1998-12-17
ES2159683T3 (es) 2001-10-16
FI973362A0 (fi) 1997-08-15
BR9607722A (pt) 1998-07-14
WO1996025154A1 (en) 1996-08-22
IL116997A0 (en) 1996-06-18
FI973362A (fi) 1997-08-15
MX9706143A (es) 1997-11-29
CO4700408A1 (es) 1998-12-29
CN1181007A (zh) 1998-05-06
YU6196A (sh) 1998-09-18
EP0727208A1 (en) 1996-08-21
EP0727208B1 (en) 2001-08-16
PE17897A1 (es) 1997-06-12
KR19980702239A (ko) 1998-07-15
NZ302147A (en) 1998-10-28
CA2212874A1 (en) 1996-08-22
JPH11505513A (ja) 1999-05-21
US5858393A (en) 1999-01-12
NO973715D0 (no) 1997-08-12
HUP9802070A3 (en) 2000-09-28

Similar Documents

Publication Publication Date Title
KR0184867B1 (ko) 2-아미노-6-n-프로필아미노-4,5,6,7-테트라하이드로벤조티아졸의 경피투여
JP6298034B2 (ja) 経皮吸収治療システム
KR0180030B1 (ko) 테스토스테론의 공급을 위한 피부패치 및 방법
JP2010500992A (ja) アルツハイマー病の経皮的治療法及び経皮的治療システム
NO973715L (no) Transdermal formulering
EP1471892B1 (en) Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
US20030026830A1 (en) Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
SE462895B (sv) Transdermal farmaceutisk komposition bestaaende av ett kolinergt eller antikolinergt medel och en laagmolekylaer fettsyra samt ett foerband eller en kompress innehaallande kompositionen
KR20050116365A (ko) 경피성 그라니세트론
US20040101550A1 (en) Transdermal therapeutic system
JP2012116859A (ja) 認知および記憶を改善するための組成物
AU709379B2 (en) Transdermal formulation
US20130273138A1 (en) Transdermal formulations of geranylgeranylacetone
US5605701A (en) Transdermal formulation
KR20000065244A (ko) 알즈하이머 질환 치료용 경피 투여 프로펜토필린 조성물
US6592893B1 (en) Transdermal patch and topical compositions comprising propylnorapomorphine
CN109999012A (zh) 一种普拉克索透皮贴剂及其制备方法
MXPA97006143A (en) Transderm formulation
KR102155108B1 (ko) 라사길린 또는 그의 약학적으로 허용가능한 염을 함유하는 경피흡수제제
Kruti et al. Novel Drug Delivery Approach: Transdermal Drug Delivery System–A Review